Insilico Medicine moves its AI-discovered treatment for idiopathic pulmonary fibrosis into late-stage testing, marking an important step for the future of artificial intelligence in drug development
Boston, Massachusetts, 9 July 2026 – Artificial intelligence is playing an increasingly important role...
The company's €45 million expansion brings research, development, and GMP manufacturing together under one roof, helping accelerate the journey from scientific discovery to commercial production
Tartu, Estonia, 2 July 2026 – The demand for biologic medicines continues to grow as...
The new research collaboration aims to combine scientific expertise and advanced discovery platforms to develop innovative medicines for patients worldwide
Indianapolis, Indiana, 25 June 2026 – The pharmaceutical industry continues to strengthen its focus on collaboration as companies look for...
The 5th In Vivo Cell Engineering & Gene Editing Summit returns to Boston this July, bringing together the scientific, translational, regulatory, and corporate leaders driving one of the fastest-accelerating fields in cell and gene therapy.
Following more than $7.3 billion...
Insilico Medicine moves its AI-discovered treatment for idiopathic pulmonary fibrosis into late-stage testing, marking an important step for the future of artificial intelligence in drug development
Boston, Massachusetts, 9 July 2026 – Artificial intelligence is playing an increasingly important role...
The company's €45 million expansion brings research, development, and GMP manufacturing together under one roof, helping accelerate the journey from scientific discovery to commercial production
Tartu, Estonia, 2 July 2026 – The demand for biologic medicines continues to grow as...
The new research collaboration aims to combine scientific expertise and advanced discovery platforms to develop innovative medicines for patients worldwide
Indianapolis, Indiana, 25 June 2026 – The pharmaceutical industry continues to strengthen its focus on collaboration as companies look for...
The 5th In Vivo Cell Engineering & Gene Editing Summit returns to Boston this July, bringing together the scientific, translational, regulatory, and corporate leaders driving one of the fastest-accelerating fields in cell and gene therapy.
Following more than $7.3 billion...
Insilico Medicine moves its AI-discovered treatment for idiopathic pulmonary fibrosis into late-stage testing, marking an important step for the future of artificial intelligence in drug development
Boston, Massachusetts, 9 July 2026 – Artificial intelligence is playing an increasingly important role...
The company's €45 million expansion brings research, development, and GMP manufacturing together under one roof, helping accelerate the journey from scientific discovery to commercial production
Tartu, Estonia, 2 July 2026 – The demand for biologic medicines continues to grow as...
The new research collaboration aims to combine scientific expertise and advanced discovery platforms to develop innovative medicines for patients worldwide
Indianapolis, Indiana, 25 June 2026 – The pharmaceutical industry continues to strengthen its focus on collaboration as companies look for...
The 5th In Vivo Cell Engineering & Gene Editing Summit returns to Boston this July, bringing together the scientific, translational, regulatory, and corporate leaders driving one of the fastest-accelerating fields in cell and gene therapy.
Following more than $7.3 billion...
